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This summer, the Pulmonary Vascular Research Institute
(PVRI) celebrates its ten-year anniversary. The bold mission
of the PVRI is: ‘‘to reduce the global burden of pulmonary
vascular disease within the next two decades.’’ The PVRI
has three primary objectives: to improve the care of patients
all over the world who suffer from pulmonary vascular dis-
ease; to facilitate and accelerate research in the clinical and
basic science of the disease; and to encourage the develop-
ment of new therapies. Timely publication of new advances
in basic, translational, and clinical research on pulmonary
vascular disease is a critical way to achieve these objectives.
The PVRI’s early foray into publishing was the Textbook
of Pulmonary Vascular Disease, edited by Jason X.-J. Yuan,
Joe G.N. Garcia, Charles A. Hales, Stuart Rich, Stephen L.
Archer, and John B. West. Writing and editing began in
2008; Springer published the textbook in 2011. This book
combines basic scientific knowledge on the pulmonary cir-
culatory system at levels of the molecule, cell, tissue, and
organ with clinical diagnosis and treatment of pulmonary
vascular diseases. State-of-the-art techniques and their
potential applications in research, diagnosis, and treatment
of pulmonary vascular diseases are also explained. A second
edition of the book is in the planning stage now.
When members of the PVRI launched the journal in
2011, no one knew what to expect. Were there enough
researchers in clinical science, basic science, and transla-
tional science to support a new journal exclusively focused
on the pulmonary circulation and pulmonary vascular dis-
ease? The answer is now a resounding ‘‘yes!’’
After six and a half years, over 600 submissions, over 500
published articles, and over 100,000 PDF-article downloads,
Pulmonary Circulation has proven its ability to capture some
of the best original research and comprehensive reviews in
the field. The journal has a global reach with authors from
more than 65 different countries. Our goal was that
Pulmonary Circulation would become the valued journal in
the field. We believe we are well on the way to achieving that
goal.
This year, in Volume 7 of the journal, we are on track to
publish more original research articles and reviews per issue,
when compared with previous volumes. The editorial lead-
ership team has been busy with more manuscripts submitted
than in the past. This means many of you on the Editorial
Board will receive more invitations to review manuscripts
and support the continuing growth of the journal. We count
on timely reviews to show authors that we are committed to
a rapid response to their manuscripts. We count on our
Editorial Board members to support the journal by submit-
ting manuscripts to and reviewing manuscripts for the jour-
nal, reading and citing the published articles in the journal,
and recommending the journal to colleagues and students.
Pulmonary Circulation will receive its first impact factor
from Thomson Reuters this summer. The impact factor is a
measure of a journal’s citation influence in the broader lit-
erature. First, thank you to all who have submitted manu-
scripts to the journal, encouraged your colleagues to submit
manuscripts, and read the journal. We also express thanks
to authors who have cited research published in Pulmonary
Circulation; our first impact factor will reflect the depth,
breadth, and quality of the journal.
Again, we look to you, our readers and contributors, to
help sustain the journal and take us to the next level. Please
submit to us your most novel and significant original
research articles in basic, translational, and clinical research;
your comprehensive review articles on interesting topics
related to pulmonary vascular disease; your highly novel
(and rare) case reports; and your Leading Edge
Perspectives (a new type of manuscript the editorial office
is soliciting). Our Submissions Guidelines page outlines the
requirements for each article type: https://us.sagepub.com/
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As we look ahead to the next decade with the Pulmonary
Vascular Research Institute, we are grateful to all who sup-
port the journal—PVRI members, editorial board members,
authors, and readers—for helping establish our unique voice
within the world of medical publishing.
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